Spotlight on ARC: Advancing Clinical Research Excellence • Liver Spot • Hepatitis C Elimination Strategies in South Texas • Expanding Access to Obesity Treatment in Patients with MASLD and MASH: Medical and Endoscopic Interventions for Broader Patient Care • Approaching Difficult Conversations with End Stage Liver Disease Patients and...

This edition includes: • REZDIFFRA™ (Resmetirom): A New Hope for Patients with Advanced Fibrosis in Non-Cirrhotic MASH • New Treatment Options for Primary Biliary Cholangitis (PBC): IQIRVO® (elafibranor) and LIVDELZI® (seladelpar) • Hepatocellular Carcinoma in the Non-Cirrhotic Liver • The Liver Spot

This edition contains: • Introducing Andrés Gómez-Aldana, Transplant Hepatologist • Sugar, Sweeteners, and Liver • Cancer: Separating Fact from Fiction • Early Intervent ion Saves Lives: The Crucial Benefit of Early Paracentesis in Hospitalized Cirrhotic Patients Cirrhosis and Nutrition: More Food for Thought • TLI Expansion to Shavano Park Outreach Clinics in Corpus Christi and...

This edition contains the following: Introducing Dr. Jan Petrasek, Transplant Hepatologist, A New Therapy for HRS-AKI, The evolving landscape of alcohol-associated hepatitis, UH Liver Transplant Program #1 Program in US,

This edition contains the following: New Adult Hep B Vaccine Approved! Treatment for Refractory Post-Transplant CMV Infection Now Available Alcohol Related Liver Disease in Women Liver Spot: Hepatitis D Meet

This edition contains the following: TLI Welcomes Dr. Rita Lepe, Director of Hepatology Health Disparities Studies Hispanics and Liver Disease So Close But Yet So Far…Promising Drugs That Came Up

This edition contains the following: First FDA-Approved NASH Drug Expected in 2020: Quick Facts to Know The Tussle Between Resection and Liver Transplantation in the Treatment of HCC “What advice

This edition contains the following: Living Donor Liver Transplantation An Update on Nonalcoholic Steatohepatitis (NASH) from the International Liver Congress Does direct-acting antiviral exposure affect hepatocellular carcinoma recurrence in patients

This edition contains the following: A New First-Line Oral Treatment for Advanced Hepatocellular Carcinoma Comprehensive, Cutting-Edge Care at The Texas Liver Tumor Center An Update on the Management of Severe

This edition contains the following: Autoimmune Hepatitis: Current And Future Treatment Options Cholangiocarcinoma: Diagnosis And Management Is Green Tea Good For Your Health? What Noninvasive Imaging Techniques Can Measure Liver